“Encourage” early feedback on the severity of Omicron: Dr. Fauci | Coronavirus Pandemic News

Top US epidemiologists say that early data from the new variants do not indicate a large degree of danger.

The U.S. Chief Epidemiology Counsel says that early signs of the severity of the Omicron COVID-19 variant are “somewhat encouraging,” but more information is still needed Anthony Fauci.

In an interview with CNN on Sunday, Fauci stated that “Omicron has a spreading advantage in South Africa, where the variant was first reported,” and pointed out that the country’s case levels were low before there was an “almost vertical peak. This is almost entirely Omron.”

He said: “Although it is too early to make any clear statement, so far, it does not appear to be serious.” “So far, the signal is a little encouraging.”

Medical experts have emphasized in recent days that the South African population is biased towards young people, and more serious cases may appear in the next few weeks.

Laboratory tests are underway to determine whether Omicron (a severely mutated virus strain) is more transmissible than other virus strains, resistant to vaccination and infection, or more severe. It is expected to be available within a few weeks. The results.

Omicron in 30% of U.S. states

At the same time, US health officials stated that the variant has spread to about one-third of the states in the United States, but the Delta version is still the majority of COVID-19 cases nationwide.

According to Reuters News, at least 15 states in the United States have reported Omicron cases: California, Colorado, Connecticut, Hawaii, Maryland, Massachusetts, Minnesota, Missouri, Nebraska, New Jersey, New York, Pennsylvania, Utah, Washington and Wisconsin Agency.

Many cases are fully vaccinated people with mild symptoms, although the booster status of some patients is unclear.

Stephen Hoge, president of vaccine manufacturer Moderna, told ABC News: “I think we will see a real risk of reduced vaccine effectiveness.”

“I don’t know how important this is,” Hoge added. “Will it be the kind of thing we see in the Delta variant, that is, the final vaccine is still effective, or will we see a 50% drop in effectiveness, which means we need to restart the vaccine? Vaccine.”

Moderna, like other pharmaceutical companies including Pfizer, has begun to adjust their vaccines when necessary.

So far, cases of Omicron variants have been confirmed In about 40 countries.

Efforts to adjust the vaccine

COVID-19 vaccine manufacturers are seeking to quickly adjust the vaccine to target Omicron, and US regulators have promised to conduct a rapid review, but this may still take several months.

Moderna Inc has stated that it may seek U.S. approval to update the vaccine as soon as possible in March, but company officials said in a television interview on Sunday that it still takes time to increase production.

US government officials have also been working with vaccine manufacturers Pfizer and Johnson & Johnson to develop the latest vaccine.

The United States imposed a travel ban on South Africa and seven other southern African countries last week to stop the spread of the variant.

Fauci said on Sunday that he hopes to lift the restrictions “within a reasonably reasonable time.”



Source link

Leave a Reply

Your email address will not be published.